Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Innovent Biologics (HK:1801)
HKEX:1801
Innovent Biologics (1801) Ownership - Who Owns Innovent Biologics?
5 Followers
Innovent Biologics (1801) Ownership Overview
0.00%
Insiders
11.67% Mutual Funds
7.06% Other Institutional Investors
81.27% Public Companies and
Individual Investors
The ownership structure of Innovent Biologics (HK:1801) stock is a mix of institutional, retail and individual investors. Approximately 18.73% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 81.27% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 45,645,536 | Institution | 2.80% | 216,222,904 | |
| 43,995,594 | Institution | 2.70% | 208,407,130 | |
| 34,310,291 | Institution | 2.11% | 162,527,848 | |
| 26,434,000 | Institution | 1.62% | 125,217,858 | |
| 23,132,608 | Institution | 1.42% | 109,579,164 | |
| 20,107,478 | Institution | 1.24% | 95,249,123 | |
| 19,004,647 | Institution | 1.17% | 90,025,013 | |
| 8,352,169 | Institution | 0.51% | 39,564,225 | |
| 8,129,500 | Institution | 0.50% | 38,509,442 | |
| 7,786,500 | Institution | 0.48% | 36,884,651 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 34,310,291 | Institution | 2.11% | 162,527,848 | |
| 26,434,000 | Institution | 1.62% | 125,217,858 | |
| 23,132,608 | Institution | 1.42% | 109,579,164 | |
| 20,107,478 | Institution | 1.24% | 95,249,123 | |
| 19,004,647 | Institution | 1.17% | 90,025,013 | |
| 8,352,169 | Institution | 0.51% | 39,564,225 | |
| 8,129,500 | Institution | 0.50% | 38,509,442 | |
| 7,786,500 | Institution | 0.48% | 36,884,651 | |
| 6,938,500 | Institution | 0.43% | 32,867,675 | |
| 6,413,500 | Institution | 0.39% | 30,380,750 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 20,176,978 | Institution | 1.24% | 91,318,552 | |
| 19,378,320 | Institution | 1.19% | 87,703,923 | |
| 10,877,500 | Institution | 0.67% | 52,302,558 | |
| 3,548,000 | Institution | 0.22% | 17,059,938 | |
| 3,277,000 | Institution | 0.20% | 15,756,882 | |
| 3,081,500 | Institution | 0.19% | 14,816,854 | |
| 2,903,347 | Institution | 0.18% | 13,140,189 | |
| 2,297,500 | Institution | 0.14% | 11,191,606 | |
| 1,790,047 | Institution | 0.11% | 8,567,723 | |
| 1,589,500 | Institution | 0.10% | 7,642,833 |
FAQ
Who Owns Innovent Biologics (HK:1801)?
According to the latest TipRanks data, approximately 7.06% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 81.27% is held by retail investors.
What percentage of Innovent Biologics (HK:1801) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.06% of Innovent Biologics (HK:1801) stock is held by institutional investors.
What percentage of Innovent Biologics (HK:1801) stock is held by retail investors?
According to the latest TipRanks data, approximately 81.27% of Innovent Biologics (HK:1801) stock is held by retail investors.
Who owns the most shares of Innovent Biologics (HK:1801)?
Vanguard owns the most shares of Innovent Biologics (HK:1801).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.